As of 2026-09-23, the Relative Valuation of Magenta Therapeutics Inc (MGTA) is (22.53) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.70 USD, the upside of Magenta Therapeutics Inc based on Relative Valuation is -3319.7%.
The range of the Relative Valuation is (12.45) - (27.44) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 9.8x - 23.0x | 19.5x |
| Forward P/E multiples | 9.5x - 21.7x | 16.1x |
| Fair Price | (12.45) - (27.44) | (22.53) |
| Upside | -1879.9% - -4021.6% | -3319.7% |
| Date | P/E |